Observational studies in systemic reviews of comparative effectiveness: AHRQ and the Effective Health Care Program

Journal of Clinical Epidemiology

Volumn 64, Issue 11, 2011, Pages 1178-1186

  Norris, Susan L ^a   Atkins, David ^b   Bruening, Wendy ^c   Fox, Steven ^d   Johnson, Eric ^e   Kane, Robert ^f   Morton, Sally C ^g   Oremus, Mark ^h   Ospina, Maria ⁱ   Randhawa, Gurvaneet ^d   Schoelles, Karen ^c   Shekelle, Paul ^j   Viswanathan, Meera ^g  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b VA Quality Enhancement Research Initiative (QUERI)   (United States)

^c ECRI INSTITUTE   (United States)

^d AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

^e CENTER FOR HEALTH RESEARCH   (United States)

^f Minnesota Evidence based Practice Center   (United States)

^g RTI INTERNATIONAL   (United States)

^h MCMASTER UNIVERSITY   (Canada)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j RAND CORPORATION   (United States)

more..

Author keywords

Evidence based medicine, Research design; Observational studies; Systematic reviews, Meta analyses, Treatment outcome

Indexed keywords

ANTIOXIDANT; ATENOLOL; CARVEDILOL; TRIPTAN DERIVATIVE;

CLINICAL PRACTICE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONCEPTUAL FRAMEWORK; CONSENSUS; CONSULTATION; CORONARY ARTERY BYPASS GRAFT; DISEASE EXACERBATION; HEALTH CARE; HEALTH CARE QUALITY; HEALTH CARE UTILIZATION; HEALTH PROGRAM; HEART FAILURE; HUMAN; INTERNAL VALIDITY; LOW BACK PAIN; MEDICAL DECISION MAKING; MIGRAINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT MONITORING; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SYSTEMATIC REVIEW (TOPIC);

EID: 80053346464     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2010.04.027     Document Type: Article

References (33)

1. A. Laupacis, J.M. Paterson, M. Mamdani, A. Rostom, and G.M. Anderson Gaps in the evaluation and monitoring of new pharmaceuticals: proposal for a different approach Can Med Assoc J 169 2003 1167 1170 (Pubitemid 37491520)
2. M. Etminan, S. Gill, M. Fitzgerald, and A. Samii Challenges and opportunities for pharmacoepidemiology in drug-therapy decision making J Clin Pharmacol 46 2006 6 9 (Pubitemid 43021709)
3. R. Chou, N. Aronson, D. Atkins, A.S. Ismaila, P. Santaguida, D.H. Smith, E. Whitlock, T.J. Wilt, and D. Moher Assessing harms when comparing medical interventions: AHRQ and the Effective Health-Care Program J Clin Epidemiol 63 2010 502 512
4. L.P. Moja, E. Telaro, R. D'Amico, I. Moschetti, L. Coe, and A. Liberati Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study BMJ 330 2005 1053 1057
5. S.L. Norris, and D. Atkins Challenges in using nonrandomized studies in systematic reviews of treatment interventions Ann Intern Med 142 2005 1112 1119 (Pubitemid 40847714)
6. S. Schneeweiss, and J. Avorn A review of uses of health care utilization databases for epidemiologic research on therapeutics J Clin Epidemiol 58 2005 323 337 (Pubitemid 40601980)
7. J.P. Vandenbroucke When are observational studies as credible as randomised trials? Lancet 363 2004 1728 1731 (Pubitemid 38670333)
8. J.P.T. Higgins, and S. Green Cochrane handbook for systematic reviews of interventions 2008 John Wiley & Sons, Ltd. Chichester, UK
9. J.J. Deeks, J. Dinnes, R. D'Amico, A.J. Sowden, C. Sakarovitch, F. Song, M. Petticrew, D.G. Altman International Stroke Trial Collaborative Group; European Carotid Surgery Trial Collaborative Group Evaluating non-randomised intervention studies Health Technol Assess 7 2003 iii x 1-173
10. S. West, V. King, T.S. Carey, K.N. Lohr, N. McKoy, S.F. Sutton, and L. Lux Systems to rate the strength of scientific evidence. Evidence report/technology assessment no. 47 2002 Agency for Healthcare Research & Quality Rockville, MD
11. E. von Elm, D.G. Altman, M. Egger, S.J. Pocock, P.C. Gotzsche, and J.P. Vandenbroucke The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies Lancet 370 2007 1453 1457
12. M. Helfand, and H. Balshem AHRQ series, paper 2: principles for developing guidance: AHRQ and the Effective Health-care Program J Clin Epidemiol 63 2010 484 490
13. N. Black Why we need observational studies to evaluate the effectiveness of health care BMJ 312 1996 1215 1218 (Pubitemid 26136714)
14. GRADE Working Group Grading quality of evidence and strength of recommendations BMJ 328 2004 1490 1498
15. D.K. Owens, K.N. Lohr, D. Atkins, J.R. Treadwell, J.T. Reston, E.B. Bass, S. Chang, and M. Helfand Grading the strength of a body of evidence when comparing medical interventions: Agency for Healthcare Research and Quality and the Effective Health Care Program J Clin Epidemiol 63 2010 513 523
16. McDonagh M, Peterson K, Carson S, Chan B, Thakurta, S. 2008. Drug Effectiveness Review Project, Drug class review: atypical antipsychotic drugs, final report update 2. Portland, OR: Oregon Evidence-based Practice Center.
17. G. Gartlehner, R.A. Hansen, D. Nissman, K.N. Lohr, and T.S. Carey A simple and valid tool distinguished efficacy from effectiveness studies J Clin Epidemiol 59 2006 1040 1048 (Pubitemid 44374310)
18. D.M. Bravata, K.M. McDonald, A.L. Gienger, V. Sundaram, M.V. Perez, R. Varghese, J.R. Kapoor, R. Ardehali, M.C. McKinnon, and C.D. Stave Comparative effectiveness of percutaneous coronary interventions and coronary artery bypass grafting for coronary artery disease 2007 Agency for Healthcare Research and Quality Rockville, MD
19. P.M. Rothwell External validity of randomised controlled trials: "to whom do the results of this trial apply?" Lancet 365 2005 82 93 (Pubitemid 40082150)
20. Atkins D, Chang S, Gartlehner G, Buckley DI, Whitlock E, Berliner E, Matchar D. Assessing the applicability of studies when comparing medical interventions. Agency for Healthcare Research and Quality; December 2010. Methods Guide for Comparative Effectiveness Reviews. AHRQ Publication No. 11-EHC019-EF. Available at http://effectivehealthcare.ahrq.gov/.
21. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
22. M. Oremus, M. Hanson, R. Whitlock, E. Young, A. Gupta, A. Dal Cin, C. Archer, and P. Raina The uses of heparin to treat burn injury. Evidence report/technology assessment no. 148. (Prepared by the McMaster University Evidence-based Practice Center, under Contract N. 290-02-0020). AHRQ Publication No. 07-E004 2006 Agency for Healthcare Research and Quality Rockville, MD
23. M. Helfand, and K. Peterson Drug class review on the triptans 2003 Drug Effectiveness Review Project, Oregon Evidence-based Practice Center Portland, OR
24. P. Glasziou, I. Chalmers, M. Rawlins, and P. McCulloch When are randomised trials unnecessary? Picking signal from noise BMJ 334 2007 349 351 (Pubitemid 46328045)
25. B.C. Reeves, J.J. Deeks, J.P.T. Higgins, and G.A. Wells Chapter 13: Including nonrandomized studies J.P.T. Higgins, S. Green, Cochrane handbook for systematic reviews 2008 John Wiley & Sons, Ltd. Chichester, UK
26. A.S. Go, J. Yang, J.H. Gurwitz, J. Hsu, K. Lane, and R. Platt Comparative effectiveness of different beta-adrenergic antagonists on mortality among adults with heart failure in clinical practice Arch Intern Med 168 2008 2415 2421
27. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920 (Pubitemid 37323253)
28. J.L. Hutten, and P.R. Williamson Bias in meta-analysis due to outcome variable selection within studies J Royal Stat Soc C 49 2000 359 370
29. A.W. Chan, A. Hrobjartsson, M.T. Haahr, P.C. Gotzsche, and D.G. Altman Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles JAMA 291 2004 2457 2465 (Pubitemid 38669189)
30. A.W. Chan, K. Krleza-Jeric, I. Schmid, and D.G. Altman Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research Can Med Assoc J 171 2004 735 740 (Pubitemid 39319090)
31. T.A. Furukawa, N. Watanabe, I.M. Omori, V.M. Montori, and G.H. Guyatt Association between unreported outcomes and effect size estimates in Cochrane meta-analyses JAMA 297 2007 468 470 (Pubitemid 46220797)
32. J. Peters, K. Mengersen, J. Peters, and K. Mengersen Selective reporting of adjusted estimates in observational epidemiology studies: reasons and implications for meta-analyses Eval Health Prof 31 2008 370 389
33. G.H. Guyatt, A.D. Oxman, G.E. Vist, R. Kunz, Y. Falck-Ytter, P. Alonso-Coello, H.J. Schunemann GRADE Working Group GRADE: an emerging consensus on rating quality of evidence and strength of recommendations BMJ 336 2008 924 926 (Pubitemid 351632017)